|Opens resource in a 2nd browser window.|
Bio-Preserve Medical Corp.
Bio-Preserve Medical Corp. develops fully automated perfusion devices for isolated organ research.
BioTime is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery.
“BioTransplant Incorporated, is
developing therapeutics based on its proprietary ImmunoCognance(tm) technology to re-educate the body’s immune system to accept transplanted cells, tissues and organs.”
Selective Genetics is developing site-specific gene-based therapeutics primarily for tissue repair and regeneration.
Tissue Therapeutics, Inc.
The focus of the company is to apply the techniques of biochemical engineering to develop medically useful cellular products from human umbilical cord blood and other sources of stem cells.